韩国禁止像 Wegovy 那样为遏制滥用而远程开具减重药品。 South Korea bans remote prescribing of weight loss drugs like Wegovy, aiming to curb abuse.

韩国卫生部计划禁止像Wegovy这样的远程减重药物处方, South Korea's health ministry plans to ban remote prescribing of weight loss drugs like Wegovy, effective Monday with a two-week grace period. 这一行动旨在遏制虐待和非法买卖,特别是民众Wegovy的滥用和非法买卖。 The move aims to curb abuse and illegal sales, especially of the popular Wegovy. 政府将制定在2025年年中之前就这些药物进行远程医疗咨询的准则。 The government will set guidelines for telemedicine consultations on these medications by mid-2025. 这一禁令是在实习医生罢工导致的远程医疗临时津贴之后实行的。 This ban follows a temporary allowance for telemedicine due to a trainee doctor strike.